Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Exp Neurol. 2017 Aug 31;298(Pt A):104–111. doi: 10.1016/j.expneurol.2017.08.016

Figure 5. CXCR2 pepducin partially decreased neutrophil mobilization and recruitment to the ischemic brain.

Figure 5

Flow cytometric analysis of blood and brain neutrophils in control peptide and CXCR2 pepducin treated mice 24 h after transient (90-minute) MCA occlusion. CD45hi leukocytes were gated on the myeloid and neutrophil-specific markers, CD11b and Ly6G, as shown.